A blood test that identifies a distinct hormonal pattern could soon help doctors diagnose endometriosis, a condition affecting roughly 10% of women of reproductive age. Researchers at the University of Edinburgh discovered that people with endometriosis show unique hormone signatures that differ from those without the condition.

Currently, endometriosis diagnosis requires invasive procedures like laparoscopy, a surgical examination of the pelvic region. This means many people suffer for years without confirmation. The average diagnostic delay stretches to seven to nine years, during which patients endure severe pelvic pain, heavy bleeding, and fertility issues without proper treatment.

The Edinburgh team analyzed hormone levels in blood samples and identified patterns specific to endometriosis. Their findings suggest a simple blood test could replace or reduce the need for surgery, offering a faster, less invasive path to diagnosis.

Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus, causing inflammation and pain. The condition affects quality of life significantly but remains underdiagnosed because symptoms mimic other disorders and diagnosis has traditionally required surgery.

A blood-based test would transform patient outcomes. People could receive confirmation and start treatment sooner, potentially preventing disease progression and preserving fertility. This matters because early intervention with medications or surgery can slow endometriosis growth.

The research represents progress toward what medical teams have sought for decades. Dr. Andrew Horne and colleagues at Edinburgh's MRC Centre for Reproductive Health continue refining these hormone markers to ensure accuracy before clinical application.

The findings require validation in larger studies before hospitals can implement blood testing clinically. Researchers must confirm the hormone signatures remain consistent across diverse populations and different disease stages.

If validated, this approach could reduce unnecessary surgeries while identifying patients who need intervention fastest. For the estimated 190 million people worldwide with endometriosis, a blood test offers hope of